Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-1-11
pubmed:abstractText
Whereas the genetic risk for type 1 diabetes is linked to human leukocyte antigen (HLA) class II genes, the HLA association in type 2 (non-insulin-dependent) diabetes is less clear. The association between HLA class II genotypes and type 2 diabetes was examined in adult Bahrainis, an Arab population with a high prevalence of type 2 diabetes. HLA-DRB1* and -DQB1* genotyping of 86 unrelated type 2 diabetes patients (age, 51.6+/-8.2 years; mean duration of diabetes, 7.7+/-7.1 years) who had a strong family history of diabetes (52 of 72 versus 0 of 89 for controls, P<0.001) and 89 healthy subjects was done by PCR-sequence-specific priming. DRB1*040101 (0.1221 versus 0.0562, P=0.019) and DRB1*070101 (0.2151 versus 0.0843, P<0.001) were positively associated, while DRB1*110101 (0.0698 versus 0.1461, P=0.014) and DRB1*160101 (0.0640 versus 0.1236, P=0.038) were negatively associated with type 2 diabetes. DRB1*040101-DQB1*0302 (0.069 versus 0.0007; P=0.004), DRB1*070101-DQB1*0201 (0.178 versus 0.0761, P=0.007), DRB1*070101-DQB1*050101 (0.125 versus 0.0310, P=0.002), and DRB1*150101-DQB1*060101 (0.0756 versus 0.0281, P=0.008) were more prevalent among patients, while DRB1*160101-DQB1*050101 (0.0702 versus 0.0349, P=0.05) was more prevalent among controls, conferring disease susceptibility or protection, respectively. In Bahrainis with type 2 diabetes, there is a significant association with select HLA class II genotypes, which were distinct from those in type 1 diabetes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-10333055, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-10333903, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-10585618, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-10834414, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-10999832, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-11082516, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-11158011, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-11812768, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-12022291, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-12507821, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-12788886, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-15013978, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-1679401, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-2731409, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-2892607, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-2967143, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-3275559, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-3384181, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-3879724, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-6350082, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-6581663, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-6942207, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-7297796, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-7554346, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-9203460, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-9475358, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-9614611, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-9760954, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-9833930, http://linkedlifedata.com/resource/pubmed/commentcorrection/15643010-9892237
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1071-412X
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
213-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Susceptible and protective human leukocyte antigen class II alleles and haplotypes in bahraini type 2 (non-insulin-dependent) diabetes mellitus patients.
pubmed:affiliation
Nelson R. Mandela School of Medicine, University of Natal, Durban, South Africa.
pubmed:publicationType
Journal Article, Comparative Study